Skip to search.
 TSX Up 0.37% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Transition Therapeutics Inc. (TTHI)

-NasdaqGM
5.59 Up 0.05(0.90%) Apr 17, 4:00PM EDT
Add to Portfolio
Prev Close:5.54
Open:5.54
Bid:N/A
Ask:7.39 x 100
1y Target Est:12.38
Beta:0.98
Next Earnings Date:N/A
Day's Range:5.31 - 5.67
52wk Range:1.93 - 8.22
Volume:82,674
Avg Vol (3m):53,575
Market Cap:165.49M
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
TTHIUp 0.90%165.49M
GSKDown 0.59%125.79B
MRKUp 0.37%166.06B
PFEUp 0.53%193.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-14) :-0.56
Quarterly EPS Est (Mar-14) :-0.07
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, develops therapeutics for various disease indications primarily in Canada. Its lead CNS drug candidate includes ELND005, a Phase II clinical trial product for the treatment of Alzheimer... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback